DXR
DXR
NASDAQ · Health Care

Daxor Corp

$10.75
+0.25 (+2.38%)
As of May 16, 2:17 AM ET ·
Financial Highlights (FY 2026)
Revenue
31.2K
Net Income
10.68M
Gross Margin
-3,917.2%
Profit Margin
34,356.6%
Rev Growth
-51.2%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin -3,917.2% -3,917.3% 65.2% 65.2%
Operating Margin -4,207.4% -3,786.7% 7.4% 8.1%
Profit Margin 34,356.6% 32,638.8% 8.7% 8.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 31.2K 64.0K 9.97M 8.80M
Gross Profit -1,223,860 -2,508,938 6.50M 5.73M
Operating Income -1,314,511 -2,425,297 732.9K 708.7K
Net Income 10.68M 19.71M 867.5K 729.9K
Gross Margin -3,917.2% -3,917.3% 65.2% 65.2%
Operating Margin -4,207.4% -3,786.7% 7.4% 8.1%
Profit Margin 34,356.6% 32,638.8% 8.7% 8.3%
Rev Growth -51.2% -51.2% +5.8% +5.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 18.88M 19.53M
Total Equity 43.47M 48.13M
D/E Ratio 0.43 0.41
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -1,308,097 -2,547,544 1.16M 1.05M
Free Cash Flow 750.2K 584.3K